Mirum Pharmaceuticals Stock Price History
| MIRM Stock | USD 47.57 0.59 1.26% |
Below is the normalized historical share price chart for Mirum Pharmaceuticals extending back to July 18, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Mirum Pharmaceuticals stands at 47.57, as last reported on the 1st of March, with the highest price reaching 47.99 and the lowest price hitting 46.24 during the day.
If you're considering investing in Mirum Stock, it is important to understand the factors that can impact its price. As of now, Mirum Stock is very steady. Mirum Pharmaceuticals has Sharpe Ratio of 0.0318, which conveys that the firm had a 0.0318 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Mirum Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Mirum Pharmaceuticals' Downside Deviation of 2.14, risk adjusted performance of 0.0574, and Mean Deviation of 1.77 to check out if the risk estimate we provide is consistent with the expected return of 0.0774%.
At this time, Mirum Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 1st of March 2025, Liabilities And Stockholders Equity is likely to grow to about 704.3 M, while Common Stock Total Equity is likely to drop 3,420. . At this time, Mirum Pharmaceuticals' Price Book Value Ratio is very stable compared to the past year. As of the 1st of March 2025, Price To Operating Cash Flows Ratio is likely to grow to 199.84, while Price Earnings Ratio is likely to drop (23.46). Mirum Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of July 2019 | 200 Day MA 39.8658 | 50 Day MA 46.5721 | Beta 0.963 |
Mirum |
Sharpe Ratio = 0.0318
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | MIRM | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.44 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Mirum Pharmaceuticals is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mirum Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 10.3333 | Enterprise Value Ebitda (8.85) | Price Sales 6.921 | Shares Float 38.6 M | Wall Street Target Price 64.4 |
Mirum Pharmaceuticals Stock Price History Chart
There are several ways to analyze Mirum Stock price data. The simplest method is using a basic Mirum candlestick price chart, which shows Mirum Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 20, 2025 | 53.16 |
| Lowest Price | December 18, 2024 | 40.6 |
Mirum Pharmaceuticals March 1, 2025 Stock Price Synopsis
Various analyses of Mirum Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Mirum Stock. It can be used to describe the percentage change in the price of Mirum Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Mirum Stock.| Mirum Pharmaceuticals Accumulation Distribution | 18,547 | |
| Mirum Pharmaceuticals Price Daily Balance Of Power | 0.34 | |
| Mirum Pharmaceuticals Price Action Indicator | 0.75 | |
| Mirum Pharmaceuticals Price Rate Of Daily Change | 1.01 |
Mirum Pharmaceuticals March 1, 2025 Stock Price Analysis
Mirum Stock Price History Data
The price series of Mirum Pharmaceuticals for the period between Sun, Dec 1, 2024 and Sat, Mar 1, 2025 has a statistical range of 12.56 with a coefficient of variation of 7.93. The daily prices for the period are spread out with arithmetic mean of 46.16. The median price for the last 90 days is 46.21.| Open | High | Low | Close | Volume | ||
| 02/28/2025 | 46.35 | 47.99 | 46.24 | 47.57 | 508,599 | |
| 02/27/2025 | 48.02 | 50.27 | 44.21 | 46.98 | 967,418 | |
| 02/26/2025 | 50.29 | 51.75 | 49.99 | 50.52 | 476,137 | |
| 02/25/2025 | 51.27 | 51.74 | 49.26 | 49.93 | 557,944 | |
| 02/24/2025 | 52.23 | 53.04 | 50.29 | 50.95 | 594,400 | |
| 02/21/2025 | 53.56 | 54.23 | 52.05 | 52.45 | 940,100 | |
| 02/20/2025 | 52.17 | 53.49 | 51.02 | 53.16 | 500,332 | |
| 02/19/2025 | 52.58 | 53.76 | 51.91 | 52.17 | 552,588 | |
| 02/18/2025 | 50.21 | 53.03 | 49.48 | 52.70 | 888,700 | |
| 02/14/2025 | 51.02 | 51.38 | 49.98 | 50.04 | 386,379 | |
| 02/13/2025 | 51.09 | 51.83 | 50.07 | 50.70 | 230,258 | |
| 02/12/2025 | 49.34 | 51.00 | 48.53 | 50.72 | 316,900 | |
| 02/11/2025 | 50.37 | 50.78 | 49.80 | 50.16 | 359,760 | |
| 02/10/2025 | 51.16 | 51.47 | 50.23 | 50.46 | 341,970 | |
| 02/07/2025 | 51.23 | 52.53 | 50.41 | 51.06 | 616,400 | |
| 02/06/2025 | 52.26 | 52.46 | 50.58 | 51.23 | 610,309 | |
| 02/05/2025 | 50.40 | 53.49 | 50.05 | 52.28 | 761,783 | |
| 02/04/2025 | 48.36 | 50.34 | 48.33 | 50.21 | 410,200 | |
| 02/03/2025 | 48.06 | 48.66 | 47.55 | 48.59 | 455,400 | |
| 01/31/2025 | 48.66 | 50.00 | 48.26 | 48.88 | 441,400 | |
| 01/30/2025 | 48.79 | 49.11 | 48.02 | 48.44 | 713,600 | |
| 01/29/2025 | 48.33 | 48.97 | 48.00 | 48.60 | 257,700 | |
| 01/28/2025 | 48.42 | 49.58 | 48.15 | 48.54 | 326,600 | |
| 01/27/2025 | 47.39 | 49.40 | 47.39 | 48.48 | 1,319,400 | |
| 01/24/2025 | 48.33 | 48.41 | 47.40 | 47.53 | 435,600 | |
| 01/23/2025 | 46.90 | 49.27 | 46.18 | 48.65 | 428,526 | |
| 01/22/2025 | 48.18 | 48.50 | 46.63 | 46.72 | 598,487 | |
| 01/21/2025 | 47.15 | 48.66 | 46.51 | 47.98 | 430,997 | |
| 01/17/2025 | 45.86 | 47.04 | 45.26 | 46.95 | 451,636 | |
| 01/16/2025 | 46.19 | 46.34 | 45.28 | 45.83 | 499,309 | |
| 01/15/2025 | 44.19 | 47.25 | 44.15 | 46.33 | 644,331 | |
| 01/14/2025 | 44.87 | 45.13 | 43.20 | 43.32 | 892,292 | |
| 01/13/2025 | 41.67 | 44.10 | 40.70 | 44.00 | 516,403 | |
| 01/10/2025 | 41.41 | 41.61 | 40.55 | 41.32 | 409,906 | |
| 01/08/2025 | 41.93 | 42.25 | 41.54 | 42.00 | 305,985 | |
| 01/07/2025 | 43.09 | 43.46 | 41.78 | 42.06 | 509,128 | |
| 01/06/2025 | 42.57 | 43.52 | 42.52 | 43.09 | 739,724 | |
| 01/03/2025 | 42.14 | 43.12 | 42.10 | 42.80 | 264,381 | |
| 01/02/2025 | 41.39 | 42.34 | 41.27 | 42.04 | 209,656 | |
| 12/31/2024 | 41.54 | 41.76 | 40.91 | 41.35 | 223,009 | |
| 12/30/2024 | 41.18 | 41.97 | 40.93 | 41.18 | 249,963 | |
| 12/27/2024 | 41.73 | 42.40 | 41.17 | 41.56 | 215,779 | |
| 12/26/2024 | 42.01 | 42.36 | 41.38 | 42.03 | 194,060 | |
| 12/24/2024 | 41.87 | 42.47 | 41.22 | 42.17 | 77,973 | |
| 12/23/2024 | 41.32 | 42.20 | 41.03 | 41.73 | 320,411 | |
| 12/20/2024 | 40.58 | 42.85 | 40.58 | 41.51 | 1,185,007 | |
| 12/19/2024 | 40.73 | 41.42 | 40.26 | 41.13 | 540,627 | |
| 12/18/2024 | 42.62 | 42.79 | 40.03 | 40.60 | 553,802 | |
| 12/17/2024 | 41.85 | 42.85 | 41.58 | 42.65 | 279,097 | |
| 12/16/2024 | 42.30 | 43.37 | 41.88 | 42.39 | 334,953 | |
| 12/13/2024 | 42.28 | 43.15 | 41.60 | 42.44 | 455,977 | |
| 12/12/2024 | 43.68 | 43.97 | 41.75 | 42.28 | 561,908 | |
| 12/11/2024 | 44.46 | 44.54 | 42.79 | 43.61 | 295,012 | |
| 12/10/2024 | 43.14 | 45.03 | 43.13 | 44.10 | 765,269 | |
| 12/09/2024 | 44.12 | 44.62 | 41.41 | 43.31 | 393,765 | |
| 12/06/2024 | 44.41 | 45.25 | 44.24 | 44.67 | 300,798 | |
| 12/05/2024 | 45.50 | 45.95 | 44.35 | 44.40 | 304,052 | |
| 12/04/2024 | 45.65 | 46.76 | 45.02 | 45.47 | 219,494 | |
| 12/03/2024 | 46.04 | 46.73 | 45.19 | 45.59 | 200,208 | |
| 12/02/2024 | 46.51 | 46.67 | 44.61 | 46.21 | 301,388 | |
| 11/29/2024 | 46.56 | 47.08 | 46.09 | 46.22 | 206,870 |
About Mirum Pharmaceuticals Stock history
Mirum Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mirum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mirum Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mirum Pharmaceuticals stock prices may prove useful in developing a viable investing in Mirum Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 47.5 M | 35.2 M | |
| Net Loss | -122.1 M | -128.2 M |
Mirum Pharmaceuticals Quarterly Net Working Capital |
|
Mirum Pharmaceuticals Stock Technical Analysis
Mirum Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Mirum Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mirum Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Mirum Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mirum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0574 | |||
| Jensen Alpha | 0.1838 | |||
| Total Risk Alpha | 0.2294 | |||
| Sortino Ratio | 0.0831 | |||
| Treynor Ratio | 0.1213 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mirum Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Mirum Stock, please use our How to Invest in Mirum Pharmaceuticals guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mirum Pharmaceuticals. If investors know Mirum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mirum Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.85) | Revenue Per Share | Quarterly Revenue Growth 0.429 | Return On Assets | Return On Equity |
The market value of Mirum Pharmaceuticals is measured differently than its book value, which is the value of Mirum that is recorded on the company's balance sheet. Investors also form their own opinion of Mirum Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Mirum Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mirum Pharmaceuticals' market value can be influenced by many factors that don't directly affect Mirum Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mirum Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mirum Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mirum Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.